Lower-dose post-transplant cyclophosphamide in haploidentical hematopoietic cell transplantation

Affiliations

• ¹ Department of Hematology, Osaka International Cancer Institute, Osaka, Japan. fujishige1231@gmail.com.
• ² Department of Hematology, Osaka Metropolitan University Hospital, Osaka, Japan.
• ³ Department of Hematology, Sapporo Hokuyu Hospital, Hokkaido, Japan.
• ⁴ Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
• ⁵ Department of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Graduate School of Medicine, Matsuyama, Ehime, Japan.
• ⁶ Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
• ⁷ Department of Hematology, Yokohama Minami Kyosai Hospital, Yokohama, Kanagawa, Japan.
• ⁸ Department of Hematology and Rheumatology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.
• ⁹ Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan.
• ¹⁰ Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan.
• ¹¹ Department of Medical Oncology and Hematology, Kobe University Hospital, Kobe, Japan.